Piperazine-Thiourea Hybrids as Novel Antiplatelet Agents Targeting COX-1: Synthesis, in Vitro, and in Silico Evaluation
Abstract
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, reinforcing the need for safer and more effective antiplatelet therapies. In this work, we designed and synthesized a series of piperazine-derived thioureas under mild conditions and evaluated their antiplatelet potential through in vitro and in silico approaches. Four derivatives (3a, 3g, 3j, and 3p) significantly inhibited arachidonic acid (AA)-induced platelet aggregation in human platelet-rich plasma, achieving levels comparable to aspirin at the same concentration. These compounds showed no anticoagulant effects or hemolytic toxicity, indicating selective action on primary hemostasis and favorable hemocompatibility. ADMET predictions supported their drug-like properties and low toxicity risk. Molecular docking and molecular dynamics simulations revealed stable interactions with key COX-1 residues, while MM-PBSA calculations confirmed favorable binding energies for the most potent derivatives. Our findings revealed that most active piperazine thioureas demonstrated promising potential as novel antiplatelet agents, offering opportunities to improve the quality of life for individuals affected by or at risk of CVDs.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.